ID: ALA4761007

Max Phase: Preclinical

Molecular Formula: C18H18F3N3O3

Molecular Weight: 381.35

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C(=O)O)nc(N2CCC(OCc3ccccc3C(F)(F)F)C2)n1

Standard InChI:  InChI=1S/C18H18F3N3O3/c1-11-8-15(16(25)26)23-17(22-11)24-7-6-13(9-24)27-10-12-4-2-3-5-14(12)18(19,20)21/h2-5,8,13H,6-7,9-10H2,1H3,(H,25,26)

Standard InChI Key:  DYKSHMYSIXRYAI-UHFFFAOYSA-N

Associated Targets(Human)

Plasma retinol-binding protein 718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Transthyretin 2847 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 381.35Molecular Weight (Monoisotopic): 381.1300AlogP: 3.30#Rotatable Bonds: 5
Polar Surface Area: 75.55Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.55CX Basic pKa: 5.87CX LogP: 2.00CX LogD: 0.58
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.86Np Likeness Score: -1.37

References

1. Cioffi CL,Muthuraman P,Raja A,Varadi A,Racz B,Petrukhin K.  (2020)  Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.,  63  (19): [PMID:32878437] [10.1021/acs.jmedchem.0c00996]

Source